Akorn Inc. (AKRX)
Symbol Info
Listed Symbol AKRX
Name Akorn Inc.
Share Info
Annual Info
Latest Fiscal Dividend Per Share $-
Latest Fiscal Date 2018-12-31
Latest Fiscal Revenue $694,018,000
Latest Fiscal EPS $-3.21
Price Info
21 Day Moving Average $3.9836
21 Day EMA $3.964390
50 Day Moving Average $3.4279
50 Day EMA $3.743590
200 Day EMA $5.026550
200 Day Moving Average 3.762530
52 Week High $7.52
52 Week Low $2.34
52 Week Change $-34.142900
Alpha -0.028658
Beta 1.8831
Standard Deviation 0.200581
R2 0.103942
Periods 60
Share Information
10 Day Average Volume 1,432,682
20 Day Average Volume 1,426,771
30 Day Average Volume 1,955,549
50 Day Average Volume 2,070,287
Outstanding Shares 126,142,943
Float Shares 119,196,425
Percent Float 94.49%
Short Interest -
Short Percent Float -
Short Interest Ratio -
Short Date
Holders
Institutions 399
Institute Holdings Date 2019-09-30
Institute Bought Previous 3 Months 11,017,856
Institute Holdings Percent 92.200000
Institute Sold Previous 3 Months 21,630,702
Insider Holdings Date 2019-08-31
Insider Bought Previous 3 Months 3
Insider Holdings Percent 5.50%
Insider Sold Previous 3 Months -
Insiders Shares Owned 6,946,518
Price Change
7 Day Price Change $0.7000001
7 Day Percent Change 17.90%
21 Day Price Change $0.7800002
21 Day Percent Change 20.37%
30 Day Price Change $0.8500001
30 Day Percent Change 22.61%
Month To Date Price Change $0.8100
Month To Date Percent 21.32%
90 Day Price Change $0.740000
90 Day Percent Change 19.12%
Quarter To Date $0.810000
Quarter To Date Percent 21.32%
180 Day Price Change $1.840000
180 Day Percent Change 66.43%
200 Day Price Change $1.050000
200 Day Percent Change 29.49%
Year To Date $1.220000
Year To Date Percent 35.99%
Profile
Description Akorn manufactures ophthalmology and dermatology products as well as injectables. In ophthalmology, the firm primarily sells generic and over-the-counter products but has a small branded portfolio that was purchased from Merck. The firm is primarily focused on the United States.
Details
Issue Type CS
Market Cap $581,518,967
Sec Type EQS
Auditor BDO USA, LLP
Total Shares Outstanding 126,142,943
CEO Douglas Boothe
Employees 2,220
Last Audit UQ
Classification
CIK 0000003116
Industry Drug Manufacturers
Sector Healthcare
NAICS Pharmaceutical Preparation Manufacturing(325412)
Info
Address 1925 West Field Court
Suite 300
Lake forest, IL 60045
Website http://www.akorn.com
Facisimile +1 800 943-3694
Telephone +1 847 279-6100
Email investor.relations@akorn.com
Key Ratios
Profitability
EBIT Margin -22.9
EBITDA Margin -11.1
Pre-Tax Profit Margin -2.5
Profit Margin Cont -82.21
Gross Margin 30.80
Profit Margin TOT -82.21
Income Statements
Revenue $497,314,000
Revenue Per Share $3.9425
Revenue 3 Years $-19.23
Revenue 5 Years $1.31
Valuation Measures
PE Ratio -
Enterprise Value $1,153,710,183
Price To Sales 1.169320
Price To Free Cash -5
PE High Last 5 Years -
Price To Book 1.9
Price To Cash Flow 115.7
PE Low Last 5 Years -
Price To Tangible Book -1.9
Financial Strength
Total Debt To Equity 3.3
Int Coverage -
Current Ratio 0.5
Leverage Ratio 6.3
Quick Ratio 0.3
Long Term Debt To Capital 0.08
Assets
Receivables Turnover 1.2
Invoice Turnover 2.40
Assets Turnover 0.10
Management Effectiveness
Return Assets -29.93
Return On Equity -97.45
Return On Capital -27.49
Dividends
Dividend 3 Years $-
Dividend 5 Years $-
Ex Dividend Date
Dividend Rate $-
Dividend Yield -
Payment Type


Your Recent History
NASDAQ
AKRX
Akorn
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.